The new center will handle the delivery of novel and high-quality therapeutics by providing expertise in critical analytical processes and specialized workflows.
Thermo Fisher Scientific announced on Nov. 13, 2019 that it is opening a customer solutions center in Shanghai, China, furthering the company’s efforts to expand its presence in China. The company also recently announced the opening of a biosciences customer exploration center in Shanghai and the expansion of its clinical trials logistics facility in Suzhou, China.
According to a company press release, the new center will handle the delivery of novel and high-quality therapeutics by providing expertise in critical analytical processes and specialized workflows.
"The opening of a Pharma and BioPharma [c]ustomer [s]olution [c]enter in China demonstrates our unwavering commitment to bringing best-in-class analytical technologies to laboratories across the region and supporting quality-by-design through scientific collaboration by scientists," said Tony Acciarito, president of Thermo Fisher Scientific in China, in the press release. "The new [c]enter reinforces our mission of enabling our customers to make the world healthier, cleaner, and safer by helping laboratories in China nurture innovation and bring effective medicines to waiting patients."
"Thermo Fisher's new [c]ustomer [s]olution ]c]enter in Shanghai is a hub of collaboration that will enable scientists across China to build new analytical workflows, enhance knowledge across our thriving pharmaceutical and biopharmaceutical sector, and help build capability and expertise in the region,” added Zhong Feng, director, Shandong New Time Pharmaceutical, in the press release.
Source: Thermo Fisher Scientific
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.